Multimodality Therapy for Locally-Advanced Cancer of the Esophagus or Gastroesophageal Junction
Publication Date: November 2, 2023
Last Updated: November 14, 2023
Induction Chemotherapy
Induction chemotherapy before preoperative CRT with a positron emission tomography (PET)-based response assessment and adaptation of the regimen accordingly during CRT may be reasonable in patients with resectable esophageal adenocarcinoma (AC). (IIb, B-NR)
573
Neoadjuvant Chemotherapy vs Neoadjuvant CRT
In patients with locally-advanced SCC of the esophagus, nCRT is reasonable to choose over neoadjuvant chemotherapy (nCT). (IIa, B-R)
573
Overview
Title
Multimodality Therapy for Locally-Advanced Cancer of the Esophagus or Gastroesophageal Junction
Authoring Organizations
Feedback